Hi. My name is Dr. Vasu Rajpal
Hello, Dr. Rajpal! It's great to meet you. How can I assist you today?
Primigravida patient with bronchial asthma. Third trimester. Management b
Reading File
Finding Sources
Searching PubMed
"asthma" AND "pregnancy" AND "management"
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from top textbooks. Let me compile the full management guide.
Bronchial Asthma in Pregnancy (Third Trimester) - Management
Dr. Rajpal, here is a structured clinical guide based on Creasy & Resnik's Maternal-Fetal Medicine and Fishman's Pulmonary Diseases.
Key Principle
Uncontrolled asthma is more dangerous than asthma medications. The primary goal is maintaining adequate maternal oxygenation to protect the fetus from hypoxic episodes. Good asthma control is the main goal, and medication risk is lower than the risk of adverse outcomes from untreated disease.
Effects on the Third Trimester
- Asthma exacerbations peak between 17-32 weeks, and may improve in the last few weeks due to higher cortisol levels
- Poorly controlled asthma is associated with:
- Preeclampsia, gestational diabetes
- Preterm birth, low birth weight, SGA
- Antepartum/postpartum hemorrhage
- Anemia and depression
Four Core Components of Management
1. Objective Monitoring
- FEV1 is the gold standard (reduced <80% = increased risk of preterm delivery <32 weeks and <37 weeks, and birth weight <2500g)
- PEFR acceptable alternative (normal range in pregnancy: 380-550 L/min)
- Green zone: >80% of personal best
- Yellow zone: 50-80%
- Red zone: <50% (requires immediate intervention)
- Patients with moderate-severe asthma: daily PEFR monitoring
- Patients with persistent asthma: review at least monthly
2. Trigger Avoidance
- Avoid: tobacco smoke, animal dander, dust mites, cockroach antigens, pollens, molds, strong odors
- Avoid: aspirin, NSAIDs, beta-blockers (exacerbate bronchospasm)
- Treat GERD (a common trigger, more prevalent in pregnancy)
- Exercise-induced asthma: pre-treat with inhaled albuterol 10-15 min before exercise
3. Patient Education
- Reassure about safety of medications - fear of drug effects is a leading cause of non-adherence
- Adherence to inhaled corticosteroids is critical - non-adherence strongly associated with exacerbations
- Provide a written action plan
4. Pharmacologic Therapy (Step-Care Approach)
| Step | Severity | Preferred Controller | Alternative |
|---|---|---|---|
| 1 | Intermittent | None (SABA PRN only) | - |
| 2 | Mild Persistent | Low-dose ICS | LTRA, theophylline, cromolyn |
| 3 | Moderate Persistent | Medium-dose ICS or Low ICS + LABA | Low ICS + LABA/LTRA/theophylline |
| 4 | Moderate-Severe | Medium-dose ICS + LABA | Medium ICS + LTRA or theophylline |
| 5 | Severe Persistent | High-dose ICS + LABA | - |
| 6 | Very Severe | High ICS + LABA + oral prednisone | - |
Rescue (all steps): Inhaled albuterol (salbutamol) - SABA of choice; has the most safety data in pregnancy
Specific Drug Safety in Pregnancy
| Drug Class | Preferred Agent | Notes |
|---|---|---|
| SABA (rescue) | Albuterol/Salbutamol | Most safety data; drug of choice |
| Inhaled corticosteroid | Budesonide | Preferred ICS; most pregnancy data |
| LABA | Salmeterol, formoterol | Use only as add-on to ICS, not monotherapy |
| Leukotriene antagonist | Montelukast | Use if asthma cannot be controlled without it; FDA warning re: congenital anomalies - use cautiously |
| Theophylline | Theophylline | Alternative; monitor serum levels (target 5-12 mcg/mL in pregnancy) |
| Systemic corticosteroids | Prednisone/prednisolone | Benefits outweigh risks; use when needed without withholding; some risk of cleft palate (1st trimester), preterm labor |
| Biologics | (e.g., omalizumab) | Scarce fetal safety data; cross placenta in 2nd trimester; use only if no alternative |
Management of Acute Exacerbations in Hospital
- Oxygen - maintain SpO2 ≥95% (fetal wellbeing requires maternal PaO2 ≥70 mmHg)
- Inhaled albuterol - 2.5-5 mg via nebulizer every 20 min x 3, then reassess
- Ipratropium bromide - add for moderate-severe exacerbations (0.5 mg nebulized)
- Systemic corticosteroids - IV methylprednisolone or oral prednisolone; do NOT withhold
- Fetal monitoring - continuous electronic fetal monitoring during severe exacerbations
- Reassess FEV1/PEFR at 30-60 min intervals
- Admit if response incomplete or PEFR <70% after initial treatment
Labor and Delivery Planning (Third Trimester Specific)
- Stress-dose corticosteroids during labor if patient has been on prolonged systemic steroids during pregnancy (to prevent adrenal crisis)
- Regional anesthesia preferred for those with active or severe asthma - reduces minute ventilation, O2 consumption, and risk of hyperinflation
- If general anesthesia is required: ketamine and halogenated anesthetics are preferred
- Oxytocin - safe to use for induction/augmentation
- Prostaglandin E2 - safe
- AVOID:
- 15-methyl PGF2-alpha (Carboprost/Hemabate) - causes severe bronchospasm
- Morphine and meperidine (histamine release, bronchospasm)
- Other prostaglandins for induction
When to Consult / Co-manage
- Allergy/immunology or pulmonology consultation if:
- Severe persistent asthma
- Complications in achieving control
- Need for allergy evaluation or full pulmonary function testing
Sources: Creasy & Resnik's Maternal-Fetal Medicine, 9th Ed. (Ch. 58, pp. 1408-1416); Fishman's Pulmonary Diseases and Disorders (Ch. 96, pp. 1702-1703); Rosen's Emergency Medicine (Ch. 32)
This is a shared conversation. Sign in to Orris to start your own chat.